Hikma Pharmaceuticals (PK)【HKMPY】銘柄情報

Hikma Pharmaceuticals plc (PK) (HKMPY) 銘柄情報

リアルタイムのストリーミング引用、アイデア、ライブディスカッションのハブ

プレミアム

通貨

41.21

( -0.05% )

買値

40.75

売値

43.43

出来高

144

41.21 日の範囲 41.21

31.80 52 週間の範囲 55.3328

時価総額

8.779B

前日終値

41.23

始値

41.21

時刻

41.985

最終取引時間

財務取引量

US$ 5,934

VWAP

41.21

平均取引量 (3 か月)

US$ 822,099

発行済株式数

213,030,512

配当利回り

0.84

PER

11.18

1 株当たり利益 (EPS)

1.81

歳入

3.35B

純利益

402M

Hikma Pharmaceuticals PLC develops, manufactures, markets, and sells a range of generic, specialty, and branded pharmaceutical products. The company operates through three segments: Injectables, Hikma Rx, and Branded. The Injectables segment provides generic and specialty injectable products primari... Hikma Pharmaceuticals PLC develops, manufactures, markets, and sells a range of generic, specialty, and branded pharmaceutical products. The company operates through three segments: Injectables, Hikma Rx, and Branded. The Injectables segment provides generic and specialty injectable products primarily for use in hospitals. The Branded segment offers branded generics and in-licensed products to retail and hospital markets. The Hikma Rx segment offers oral, respiratory, and other generic and specialty products for the retail market. It provides its products in various therapeutic areas, including respiratory, oncology, and pain management. The company also offers its products in solid, semi-solid, liquid, and injectable dosage forms. It operates in the United Kingdom, Europe, North America, the Middle East, North Africa, and internationally. Hikma Pharmaceuticals PLC was founded in 1978 and is headquartered in London, United Kingdom. 詳細を表示

セクター

Healthcare

業界

Pharmaceuticals

ウェブサイト

www.hikma.com

本社

London, United Kingdom

設立

1978

Hikma Pharmaceuticals plc (PK) is listed in the Healthcare sector of the その他OTC with ticker HKMPY. The last closing price for Hikma Pharmaceuticals (PK) was US$41.23. Over the last year, Hikma Pharmaceuticals (PK) shares have traded in a share price range of US$ 31.80 to US$ 55.3328.

Hikma Pharmaceuticals (PK) currently has 213,030,512 shares in issue. The market capitalisation of Hikma Pharmaceuticals (PK) is US$8.78 billion. Hikma Pharmaceuticals (PK) has a price to earnings ratio (PE ratio) of 11.18.

Hikma comments on Supreme Court of the United States' unanimous decision in favour of Hikma

Hikma comments on Supreme Court of the United States' unanimous decision in favour of Hikma PR Newswire LONDON, June 4, 2026 LONDON, June...

Hikma Pharmaceuticals Resumes US Launch of Generic of GSK Asthma Treatment

By Anthony O. Goriainoff Hikma Pharmaceuticals PLC said Wednesday that it has resumed the launch of its generic version of GlaxoSmithKline...

Hikma, GlaxoSmithKline End Talks Over Egypt, Tunisia Deals

By Adria Calatayud Hikma Pharmaceuticals PLC said Thursday that talks have ceased over a potential acquisition of GlaxoSmithKline PLC's...

Hikma Pharmaceuticals Says It Is in Talks With GlaxoSmithKline to Buy Some Businesses

By Ian Walker Hikma Pharmaceuticals PLC said Tuesday that it has entered into a preliminary agreement with GlaxoSmithKline PLC's Egyptian...

European Companies Continue Reinstating Guidance Amid Coronavirus Uncertainty -- Roundup

By Mauro Orru This week, more European companies issued new guidance for 2020, while others revised expectations in the wake of the coronavirus...

Hikma To Join London's Blue-Chip Index as Shire Exits

By Carlo Martuscelli Hikma Pharmaceuticals PLC (HIK.LN) will joint the FTSE 100 index, replacing Shire PLC (SHP.LN), FTSE Russell said Wednesday...

Hikma Announces Tie-Up With Vectura; Raises Guidance

By Carlo Martuscelli Hikma Pharmaceuticals PLC (HIK.LN) announced Thursday a tie-up with inhaler producer Vectura Group PLC (VEC.LN) to...

Acorda Shares Tumble After Court Ruling

By Micah Maidenberg A federal court agreed that patents Acorda Therapeutics Inc. (ACOR) holds for a multiple sclerosis drug are invalid, sending...

Acorda Signs Settlement With Mylan on Generic Ampyra

By Michael Dabaie Biotechnology company Acorda Therapeutics Inc. (ACOR) on Friday said it signed a conditioned settlement agreement with Mylan...

Acorda Shares Fall as Court Denies Injunction Request in Patent Case -- Market Mover

Acorda Therapeutics Inc. (ACOR) were down 14.8%, to $24.45, Wednesday afternoon as a federal appeals court denied the company's motion for an...

期間 †	前日比	前日比 %	始値	高値	安値	平均出来高	VWAP
1	0	0	0	41.21	0	0	0	DR
4	1.9435	4.94951167025	39.2665	41.23	39	439	39.68286117	DR
12	3.96	10.6308724832	37.25	41.23	36.14	458	38.02681365	DR
26	-0.17	-0.410826486225	41.38	45.93	31.8	1367	40.71305466	DR
52	-14.1	-25.4926776351	55.31	55.3328	31.8	2759	42.87277191	DR
156	-8.436	-16.9923055231	49.646	59.26	31.8	1730	44.70331596	DR
260	-33.44	-44.7957133289	74.65	75.81	25.12	1924	45.75883593	DR

HKMPY - Frequently Asked Questions (FAQ)

What is the current Hikma Pharmaceuticals plc (PK) share price?

The current share price of Hikma Pharmaceuticals plc (PK) is US$ 41.21

How many Hikma Pharmaceuticals plc (PK) shares are in issue?

Hikma Pharmaceuticals plc (PK) has 213,030,512 shares in issue

What is the market cap of Hikma Pharmaceuticals plc (PK)?

The market capitalisation of Hikma Pharmaceuticals plc (PK) is USD 8.78B

What is the 1 year trading range for Hikma Pharmaceuticals plc (PK) share price?

Hikma Pharmaceuticals plc (PK) has traded in the range of US$ 31.80 to US$ 55.3328 during the past year

What is the PE ratio of Hikma Pharmaceuticals plc (PK)?

The price to earnings ratio of Hikma Pharmaceuticals plc (PK) is 11.18

What is the cash to sales ratio of Hikma Pharmaceuticals plc (PK)?

The cash to sales ratio of Hikma Pharmaceuticals plc (PK) is 1.29

What is the registered address of Hikma Pharmaceuticals plc (PK)?

The registered address for Hikma Pharmaceuticals plc (PK) is 10 Portman Square, London, Greater London, W1H 6AZ

What is the Hikma Pharmaceuticals plc (PK) website address?

The website address for Hikma Pharmaceuticals plc (PK) is www.hikma.com

Which industry sector does Hikma Pharmaceuticals plc (PK) operate in?

Hikma Pharmaceuticals plc (PK) operates in the Pharmaceuticals sector

市場データ

ニュース

投資ツール

市場

発見

Hot Features

Follow Feed

ライブオプションフロー

モニター

Hikma Pharmaceuticals plc (PK) (HKMPY)

Hikma Pharmaceuticals plc (PK) (HKMPY) 銘柄情報

リアルタイムのストリーミング引用、アイデア、ライブディスカッションのハブ

主要統計と詳細

Hikma Pharmaceuticals plc (PK) について

HKMPY 最新ニュース

Hikma comments on Supreme Court of the United States' unanimous decision in favour of Hikma

Hikma Pharmaceuticals Resumes US Launch of Generic of GSK Asthma Treatment

Hikma, GlaxoSmithKline End Talks Over Egypt, Tunisia Deals

Hikma Pharmaceuticals Says It Is in Talks With GlaxoSmithKline to Buy Some Businesses

European Companies Continue Reinstating Guidance Amid Coronavirus Uncertainty -- Roundup

Hikma To Join London's Blue-Chip Index as Shire Exits

Hikma Announces Tie-Up With Vectura; Raises Guidance

Acorda Shares Tumble After Court Ruling

Acorda Signs Settlement With Mylan on Generic Ampyra

Acorda Shares Fall as Court Denies Injunction Request in Patent Case -- Market Mover

Hikma comments on Supreme Court of the United States' unanimous decision in favour of Hikma

HKMPY - Frequently Asked Questions (FAQ)

HKMPY 取引

HKMPY Discussion

最近閲覧した銘柄

会社情報

ビジネス

人気

アプリを入手

市場データ

ニュース

投資ツール

市場

発見

Hot Features

Follow Feed

ライブオプションフロー

モニター

Hikma Pharmaceuticals plc (PK) (HKMPY)

Hikma Pharmaceuticals plc (PK) (HKMPY) 銘柄情報

リアルタイムのストリーミング引用、アイデア、ライブディスカッションのハブ

主要統計と詳細

Hikma Pharmaceuticals plc (PK) について

HKMPY 最新ニュース

Hikma comments on Supreme Court of the United States' unanimous decision in favour of Hikma

Hikma Pharmaceuticals Resumes US Launch of Generic of GSK Asthma Treatment

Hikma, GlaxoSmithKline End Talks Over Egypt, Tunisia Deals

Hikma Pharmaceuticals Says It Is in Talks With GlaxoSmithKline to Buy Some Businesses

European Companies Continue Reinstating Guidance Amid Coronavirus Uncertainty -- Roundup

Hikma To Join London's Blue-Chip Index as Shire Exits

Hikma Announces Tie-Up With Vectura; Raises Guidance

Acorda Shares Tumble After Court Ruling

Acorda Signs Settlement With Mylan on Generic Ampyra

Acorda Shares Fall as Court Denies Injunction Request in Patent Case -- Market Mover

Hikma comments on Supreme Court of the United States' unanimous decision in favour of Hikma

HKMPY - Frequently Asked Questions (FAQ)

HKMPY 取引

HKMPY Discussion

最近閲覧した銘柄

会社情報

ビジネス

人気

アプリを入手

ADVFNに参加する理由

プロトレーダー向けの高機能ツール

広告を削除する